However, extrapolating findings from mechanistic PINK1/Parkin studies to in vivo relevance has been a subject of much debate: Most studies that have elucidated the molecular events of Parkin-mediated mitophagy utilize a combination of artificial Parkin overexpression and chemically-induced mitochondrial depolarization in cancer cell lines. The gene discussed is PRKN; the disease is cancer.